Director · KalVista Pharmaceuticals, Inc. · KalVista Pharmaceuticals, Inc. — Stock Option (Right to Buy)
Side
D
Value
—
Shares
45.0K
Price
—
Executed
Jun 11, 2026
Disclosed
Jun 11, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jun 11 executedJun 11, 2026 disclosed
KALV · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disposition to issuer — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
KalVista Pharmaceuticals, Inc. — Stock Option (Right to Buy)
Ticker
KALV
Shares
45.0K
Execution date (reported)
Jun 11, 2026
Owned after transaction
0 shares
Days from execution to publication
0
What this establishes
Sensenig Bethany filed this Form 4 reporting a disposition to issuer of KALV on Jun 11, 2026. It became public on Jun 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Sensenig Bethanycik:0001899935
Issuer
KalVista Pharmaceuticals, Inc.cik:0001348911
Revision history · 0
No field has changed since this record was first ingested.
